Topic 80 of 138 in the MU Sofia syllabus for Internal Diseases and Therapy (Medicine, Years 4 and 5). The free AceMed note covers it in 13 sections, about 1,418 words (13 min of reading), with 19 flashcards.
In this note
In brief
Definition
Epidemiology
Etiology
Pathogenesis
Clinical features
Diagnosis
Differential diagnosis
Treatment
Complications
Prognosis
Exam lens: USMLE / PLAB
References
In brief
What it is: a goitre is an enlarged thyroid. It may be diffuse or nodular, endemic (iodine deficiency in a population) or sporadic (any other cause), and the gland can be euthyroid, underactive or overactive. Most thyroid nodules are benign; about 5–10% are cancer.
Key to diagnosis: TSH first; a low TSH leads to an isotope scan, a normal or high TSH to neck ultrasound, which sets the risk pattern and size cut-off for a fine-needle aspiration (FNA) reported in the six Bethesda categories (2023).
Key to treatment: prevent iodine deficiency (iodised salt); watch small benign nodules; treat compression, toxic nodules and cancer surgically or with radioiodine. Levothyroxine does not shrink goitres in iodine-sufficient areas.
Definition
Goitre: thyroid enlargement. WHO palpation grading: grade 0 no goitre; grade 1 palpable but not visible with the neck in the normal position; grade 2 visible. Ultrasound volume above about 18 mL in women and 25 mL in men is enlarged.
Endemic goitre: goitre in more than 5% of school-age children in a population, from iodine deficiency. Sporadic goitre: goitre from other causes in a person outside such an area. Nodular goitre: one (solitary) or several (multinodular) discrete lumps in the gland. Simple (non-toxic) goitre: neither thyrotoxic nor hypothyroid, with no inflammation or cancer.